{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:55:05Z","timestamp":1791082505114,"version":"4.1.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inherited bone marrow failure syndromes (IBMFS) cause hematopoietic stem progenitor cell (HSPC) failure due to germline mutations. Germline mutations influence the number and fitness of HSPC by various mechanisms, for example, abnormal ribosome biogenesis in Shwachman-Diamond syndrome and Diamond-Blackfan anemia, unresolved DNA cross-links in Fanconi anemia, neutrophil maturation arrest in severe congenital neutropenia, and telomere shortening in short telomere syndrome. To compensate for HSPC attrition, HSPCs are under increased replication stress to meet the need for mature blood cells. Somatic alterations that provide full or partial recovery of functional deficit implicated in IBMFS can confer a growth advantage. This review discusses results of recent genomic studies and illustrates our new understanding of mechanisms of clonal evolution in IBMFS.<\/jats:p>","DOI":"10.1182\/hematology.2021000271","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:14:00Z","timestamp":1639138440000},"page":"390-398","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":26,"title":["Mechanisms of somatic transformation in inherited bone marrow failure syndromes"],"prefix":"10.1182","volume":"2021","author":[{"given":"Haruna Batzorig","family":"Choijilsuren","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD"},{"name":"Department of Molecular and Cellular Biology, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeji","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moonjung","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"issue":"1","key":"2021121012073431600_hem2021000271C1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/asheducation-2016.1.74","article-title":"Aplastic anemia and clonal evolution: germ line and somatic genetics","volume":"2016","author":"Shimamura","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2021121012073431600_hem2021000271C2","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2352-3026(19)30206-6","article-title":"Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study","volume":"7","author":"Myers","year":"2020","journal-title":"Lancet Haematol"},{"issue":"7","key":"2021121012073431600_hem2021000271C3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ajh.25810","article-title":"Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: a retrospective analysis on behalf of EBMT group","volume":"95","author":"Giardino","year":"2020","journal-title":"Am J Hematol"},{"issue":"6465","key":"2021121012073431600_hem2021000271C4","doi-asserted-by":"crossref","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"issue":"14","key":"2021121012073431600_hem2021000271C5","first-page":"1615","article-title":"Clonal hematopoiesis in the inherited bone marrow failure syndromes","volume":"136","author":"Tsai","year":"2020","journal-title":"Blood"},{"issue":"10","key":"2021121012073431600_hem2021000271C6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jmg.40.10.721","article-title":"In vivo reversion to normal of inherited mutations in humans","volume":"40","author":"Hirschhorn","year":"2003","journal-title":"J Med Genet"},{"issue":"12","key":"2021121012073431600_hem2021000271C7","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1182\/bloodadvances.2021004345","article-title":"Approach to the diagnosis of aplastic anemia","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"2021121012073431600_hem2021000271C8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev"},{"issue":"1","key":"2021121012073431600_hem2021000271C9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"2021121012073431600_hem2021000271C10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3324\/haematol.2014.117457","article-title":"The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes","volume":"100","author":"Cada","year":"2015","journal-title":"Haematologica"},{"issue":"9","key":"2021121012073431600_hem2021000271C11","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2011.057489","article-title":"Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome","volume":"97","author":"Donadieu","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"2021121012073431600_hem2021000271C12","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41467-021-21588-4","article-title":"Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman- Diamond syndrome","volume":"12","author":"Kennedy","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"2021121012073431600_hem2021000271C13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2017-08-801985","article-title":"Somatic mutations and clonal hematopoiesis in congenital neutropenia","volume":"131","author":"Xia","year":"2018","journal-title":"Blood"},{"key":"2021121012073431600_hem2021000271C14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jbior.2017.09.002","article-title":"Molecular basis of the human ribosomopathy Shwachman- Diamond syndrome","volume":"67","author":"Warren","year":"2018","journal-title":"Adv Biol Regul"},{"issue":"16","key":"2021121012073431600_hem2021000271C15","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2011-08-375972","article-title":"Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry","volume":"119","author":"Vlachos","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2021121012073431600_hem2021000271C16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation","volume":"376","author":"Lindsley","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121012073431600_hem2021000271C17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00112","article-title":"Diamond-blackfan anemia predisposing to myelodysplastic syndrome in early adulthood","volume":"22","author":"Simkins","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"2021121012073431600_hem2021000271C18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.hoc.2018.03.005","article-title":"Significance of clonal mutations in bone marrow failure and inherited myelodysplastic syndrome\/acute myeloid leukemia predisposition syndromes","volume":"32","author":"Schaefer","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"2021121012073431600_hem2021000271C19","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1172\/JCI92069","article-title":"Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia","volume":"127","author":"Knies","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"2021121012073431600_hem2021000271C20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrc.2017.116","article-title":"Fanconi anaemia and cancer: an intricate relationship","volume":"18","author":"Nalepa","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2021121012073431600_hem2021000271C21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.stem.2012.05.013","article-title":"Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53\/p21 DNA damage response that impairs hematopoietic stem and progenitor cells","volume":"11","author":"Ceccaldi","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2021121012073431600_hem2021000271C22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"15","key":"2021121012073431600_hem2021000271C23","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","article-title":"Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions","volume":"117","author":"Quentin","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2021121012073431600_hem2021000271C24","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2002-10-3243","article-title":"Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor","volume":"101","author":"T\u00f6nnies","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2021121012073431600_hem2021000271C25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1309\/AJCP7W9VMJENZOVG","article-title":"Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with Fanconi anemia: morphologic and cytogenetic characteristics","volume":"133","author":"Cioc","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"22","key":"2021121012073431600_hem2021000271C26","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1182\/blood-2011-03-343897","article-title":"Fanconi anemia (FA)-associated 3q gains in leukemic transformation consistently target EVI1, but do not affect low TERC expression in FA","volume":"117","author":"Meyer","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2021121012073431600_hem2021000271C27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/bloodadvances.2016000943","article-title":"Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia","volume":"1","author":"Reina-Castill\u00f3n","year":"2017","journal-title":"Blood Adv"},{"issue":"6","key":"2021121012073431600_hem2021000271C28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0043-117046","article-title":"Mutational spectrum of Fanconi anemia associated myeloid neoplasms","volume":"229","author":"Chao","year":"2017","journal-title":"Klin Padiatr"},{"issue":"4","key":"2021121012073431600_hem2021000271C29","doi-asserted-by":"crossref","first-page":"e131018","DOI":"10.1172\/jci.insight.131018","article-title":"Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure","volume":"5","author":"Heidemann","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"2021121012073431600_hem2021000271C30","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1073\/pnas.051609898","article-title":"Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells","volume":"98","author":"Gregory","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2021121012073431600_hem2021000271C31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2004-05-1852","article-title":"Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA\/BRCA pathway","volume":"105","author":"Soulier","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2021121012073431600_hem2021000271C32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.26234","article-title":"Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients","volume":"96","author":"Ram\u00edrez","year":"2021","journal-title":"Am J Hematol"},{"issue":"14","key":"2021121012073431600_hem2021000271C33","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2013-11-538025","article-title":"Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis","volume":"123","author":"Skokowa","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2021121012073431600_hem2021000271C34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"2021121012073431600_hem2021000271C35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOH.0000000000000479","article-title":"Mechanisms of leukemic transformation in congenital neutropenia","volume":"26","author":"Link","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"2021121012073431600_hem2021000271C36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41580-021-00328-y","article-title":"Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization","volume":"22","author":"Lim","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"24","key":"2021121012073431600_hem2021000271C37","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med"},{"issue":"5230","key":"2021121012073431600_hem2021000271C38","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.7545310","article-title":"Telomerase and DNA end replication: no longer a lagging strand problem?","volume":"269","author":"Lingner","year":"1995","journal-title":"Science"},{"issue":"1","key":"2021121012073431600_hem2021000271C39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1182\/hematology.2020000170","article-title":"Extrahematopoietic manifestations of the short telomere syndromes","volume":"2020","author":"Schratz","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"22","key":"2021121012073431600_hem2021000271C40","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.2019003264","article-title":"Cancer spectrum and outcomes in the Mendelian short telomere syndromes","volume":"135","author":"Schratz","year":"2020","journal-title":"Blood"},{"issue":"8","key":"2021121012073431600_hem2021000271C41","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41375-018-0125-x","article-title":"Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita","volume":"32","author":"Kirschner","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"2021121012073431600_hem2021000271C42","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/ajh.24552","article-title":"Clonal hematopoiesis in patients with dyskeratosis congenita","volume":"91","author":"Perdigones","year":"2016","journal-title":"Am J Hematol"},{"issue":"3","key":"2021121012073431600_hem2021000271C43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1172\/JCI91161","article-title":"Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations","volume":"127","author":"Maryoung","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"2021121012073431600_hem2021000271C44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ajhg.2012.01.004","article-title":"Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita","volume":"90","author":"Jongmans","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2021121012073431600_hem2021000271C45","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"2021121012073431600_hem2021000271C46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2013.08.011","article-title":"Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7","volume":"24","author":"Nagamachi","year":"2013","journal-title":"Cancer Cell"},{"issue":"14","key":"2021121012073431600_hem2021000271C47","doi-asserted-by":"crossref","first-page":"e121086","DOI":"10.1172\/jci.insight.121086","article-title":"Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes","volume":"3","author":"Wong","year":"2018","journal-title":"JCI Insight"},{"issue":"21","key":"2021121012073431600_hem2021000271C48","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2017-05-787390","article-title":"Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes","volume":"132","author":"Nagata","year":"2018","journal-title":"Blood"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/390\/1852164\/390choijilsuren.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/390\/1852164\/390choijilsuren.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T05:44:59Z","timestamp":1726292699000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2021\/1\/390\/482951\/Mechanisms-of-somatic-transformation-in-inherited"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,10]]},"published-print":{"date-parts":[[2021,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2021000271","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,10]]},"published":{"date-parts":[[2021,12,10]]}}}